tiprankstipranks
Mallinckrodt appoints Peter Richardson as CSO
The Fly

Mallinckrodt appoints Peter Richardson as CSO

Mallinckrodt announced that Dr. Peter Richardson, B.Med.Sci., BM, BS, MRCP has been appointed Executive Vice President and Chief Scientific Officer, effective January 12, 2023. Dr. Richardson will have executive responsibility for Mallinckrodt’s branded research and development, medical affairs, safety, and regulatory affairs functions. He will serve on the Company’s Executive Committee and succeeds Steven Romano, M.D., who departed Mallinckrodt in December 2022. Dr. Richardson previously served as Executive Vice President, Head of Research and Development and Chief Medical Officer at Antares Pharmaceuticals, overseeing all pharmaceutical research and development activities across the organization.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles